Navigation Links
3 Common Drugs Trigger Most ER Visits by Seniors
Date:12/4/2007

Warfarin, insulin and digoxin account for a third of drug-related ER trips, study says

TUESDAY, Dec. 4 (HealthDay News) -- Side effects from just three drugs are responsible for a full third of all U.S. emergency room visits by senior citizens who had adverse reactions to medications, a new study found.

In 2004 and 2005, the blood thinner warfarin, the diabetes drug insulin and the heart drug digoxin caused about 58,000 emergency room visits a year in those 65 and older, the researchers found.

The major problem is that it's hard to determine the correct dose for each drug, said study lead author Dr. Daniel Budnitz, a medical officer with the U.S. Centers for Disease Control and Prevention (CDC).

"It's challenging," he said, "and it takes work between the patient and physician to get the dose just right."

Budnitz and his colleagues undertook the study to determine the danger posed to senor citizens by a long list of drugs that have been deemed "potentially inappropriate" for use in the elderly.

The researchers looked at several surveys of emergency room visits from 2004 and 2005. The study findings are published in the Dec. 4 issue of the Annals of Internal Medicine.

Forty-one drugs are on the list -- called the BEERS criteria -- of medications considered inappropriate for the elderly. But they accounted for just 3.6 percent of a total of about 177,000 annual emergency room visits.

Warfarin (also known as Coumadin), insulin and digoxin (which has a number of trade names) posed many more problems. (Digoxin is also on the list of potentially inappropriate drugs for the elderly, but it's only listed as a potential problem if taken in certain situations.)

All three medications are well-known, commonly used drugs and all can create problems in some cases.

Warfarin, often prescribed to heart patients, prevents blood clots by thinning the blood, but can cause excessive bleeding if the blood becomes too thin. Insulin treats diabetes but can sometimes cause blood sugar levels to drop to dangerous levels. And digoxin, a long-used drug, can cause a variety of problems from nausea to erratic heartbeats.

In some cases, there aren't good alternatives to these three drugs, although some doctors consider digoxin to have outlived its usefulness, the study authors noted.

Doctors can monitor the levels of all three drugs with blood tests, Budnitz said. Simple finger-prick blood tests allow testing of blood sugar levels, and similar tests measuring clotting ability are now available in some clinics for people taking warfarin, he said.

The study results are "a reminder that doctors and patients need to work on doing the best job we can managing these medicines," Budnitz said. "The answer isn't to take away medications."

Dr. Knight Steel, head of geriatric medicine at Hackensack University Medical Center in New Jersey, said the study results aren't really surprising. Doctors have long known the risks of the three drugs in question, he said, adding that the research doesn't provide any new information.

More information

To learn more about the health risks that drugs can pose to the elderly, visit Duke University Health System.



SOURCES: Daniel Budnitz, M.D., medical officer, U.S. Centers for Disease Control and Prevention, Atlanta; Knight Steel, M.D., chief of geriatrics, Hackensack University Medical Center, New Jersey; Dec. 4, 2007, Annals of Internal Medicine


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UK junior doctors gaining less experience of common procedures
2. New insights into common knee injuries
3. High and mighty: first common height gene identified by researchers behind obesity gene finding
4. Figure Skater Peggy Fleming, HealthSaver Says: Take Pains For Back Strains, 2nd Most Common Doctor Complaint
5. Exelixis Commences Public Offering of Common Stock
6. Common misdiagnosis: most women believe they have a yeast infection when they dont
7. Business Executives Discuss National Health Care Reform at Conference Sponsored by The Century Foundation, with Support from The Commonwealth Fund, and AARP
8. New Expert Report Dispels Common Myths About Aspartame
9. Common Foot Myths Trip Us Up
10. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
11. Allergy-Induced Asthma More Common in Affluent Countries
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
3 Common Drugs Trigger Most ER Visits by Seniors
(Date:5/25/2016)... MA (PRWEB) , ... May 25, 2016 , ... ... Research Institute (WCRI) compare outcomes of injured workers across 15 states. The ... to work, earnings recovery, access to medical care, and satisfaction with medical care. ...
(Date:5/25/2016)... ... 25, 2016 , ... Cheryl Bowker of Bowker Insurance Group has been presented ... Hands Legacy Award. McKenna ran one of Allstate’s most successful agencies for 48 years, ... who knew him. The award named for him is not given every year, but ...
(Date:5/25/2016)... ... May 25, 2016 , ... Casa Velas, an adults-only boutique hotel in ... to complement its new wellness suites . The two 1,350 sq. ft. suites ... of special services and insuite amenities, from a custom soap selection and in-suite exercise ...
(Date:5/25/2016)... ... 2016 , ... Laser Skin & Wellness Center is excited to ... of female aging. The Juliet™ procedure helps to reverse the effects ... laxity, itchiness and pain have reported real relief from these and other problems by ...
(Date:5/25/2016)... ... May 25, 2016 , ... First Choice Emergency Room , ... Anh Tat Nguyen, as the Medical Director of its new DeSoto facility. , ... our new DeSoto location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... -- The global  reprocessed medical devices market ... according to a new study by Grand View Research, ... the lack of centralized support for waste disposal in ... for reprocessed medical devices market. Additionally, the long-term cost-efficiency ... the original device is the high impact rendering driver ...
(Date:5/22/2016)... -- DS Biopharma (DS) today announced ... DS102 in chronic obstructive pulmonary disease (COPD) patients ... Recent DS preclinical data suggests that ... has bronchodilatory, anti-inflammatory and anti-fibrotic properties in the ... publish further detail on these findings later in ...
(Date:5/20/2016)... 2016 The Biotech arena remains ... the industry is not far from recovering. There are ... the following four equities: Anacor Pharmaceuticals Inc. (NASDAQ: ... ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... Sign up for your free trading alerts on these ...
Breaking Medicine Technology: